Here are Cathie Wood’s latest moves.

CRISPR Therapeutics (NasdaqGM:CRSP) has set new 2026 milestones, including planned regulatory submissions for Casgevy in patients aged 5 to 11. The company outlined progress in several clinical ...

Daryl Seaton steps into the CEO role at Sowell Management, succeeding Founder Bill Sowell, who will serve as chief strategy ...

Now that artificial intelligence platforms are proven and refined, the world needs a way of making it readily accessible to ...

Tesla shares aren't cheap, but the stock is worth a look by investors aiming to potentially compound $500.

Investors interested in quantum computing could consider ETFs focused on cloud services enabling small businesses to use big ...

Michael Fiddelke takes the top job at the struggling retailer amid continued unrest in the Twin Cities. A new boss also steps ...

In this article, we will discuss: Growth Stock Portfolio: 12 Stock Picks By Cathie Wood. After a severe 2022 decline, Cathie Wood’s flagship innovation fund witnessed a dramatic comeback through 2025, ...

On the sell side, ARK divested 13,677 shares of Kratos Defense and Security Solutions Inc (NASDAQ:KTOS) through its ARKQ ETF, totaling $1,522,523. This sale is part of a broader trend, as ARK has been ...

“AI’s next phase will be defined less by model breakthroughs and more by how effectively organizations, governments, and ...

For the fifth time, Republic Services, Inc. has been named one of the World's Most Admired Companies by Fortune. The company ...